Focus Partners Wealth
KURA icon

Focus Partners Wealth’s Kura Oncology KURA Stock Holding History

Focus Partners Wealth’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Sell
16,809
-7,850
-32% -$67.4K ﹤0.01% 2475
2025
Q4 		$256K Buy
24,659
+8,458
+52% +$88.7K ﹤0.01% 2312
2025
Q3 		$143K Buy
+16,201
New +$115K ﹤0.01% 2096

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Focus Partners Wealth's KURA Position: Q1 2026 in Review

Focus Partners Wealth reduced its Kura Oncology (KURA) stake by 32% in Q1 2026, selling an estimated $67.4K and leaving 16,809 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Focus Partners Wealth first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $256K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Focus Partners Wealth held 16,809 shares of Kura Oncology worth $137K as of Q1 2026.
  • Focus Partners Wealth sold 7,850 Kura Oncology shares in Q1 2026, an estimated $67.4K.
  • Kura Oncology made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2475 holding.
  • Focus Partners Wealth first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • Focus Partners Wealth's Kura Oncology position peaked at $256K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.